Editas Medicine (EDIT) Payables (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Payables data on file, last reported at $2.6 million in Q4 2025.

• Quarterly Payables fell 52.58% year-over-year to $2.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.6 million (down 52.58% YoY) and the FY2025 annual result came in at $2.6 million, down 52.58% from the prior year.
• Payables slipped to $2.6 million in Q4 2025 per EDIT's latest filing, from $3.2 million in the prior quarter.
• Across five years, Payables topped out at $13.8 million in Q2 2024 and bottomed at $2.6 million in Q4 2025.
• The 5-year median for Payables is $6.8 million (2022), against an average of $7.1 million.
• The widest annual swing landed in 2022, when Payables soared 100.94%; it then tumbled 74.68% in 2025.
• Tracing EDIT's Payables over 5 years: stood at $5.0 million in 2021, then soared by 88.34% to $9.5 million in 2022, then fell by 13.06% to $8.3 million in 2023, then tumbled by 33.57% to $5.5 million in 2024, then sank by 52.58% to $2.6 million in 2025.
• Per Business Quant, the three latest EDIT Payables figures stand at $2.6 million (Q4 2025), $3.2 million (Q3 2025), and $6.7 million (Q2 2025).

Peer Comparison